Autophagy: A Silent Protagonist in Kidney Transplantation.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
13 Nov 2023
13 Nov 2023
Historique:
pubmed:
13
11
2023
medline:
13
11
2023
entrez:
13
11
2023
Statut:
aheadofprint
Résumé
Autophagy is a lysosome-dependent regulated mechanism that recycles unnecessary cytoplasmic components. It is now known that autophagy dysfunction may have a pathogenic role in several human diseases and conditions, including kidney transplantation. Both defective and excessive autophagy may induce or aggravate several complications of kidney transplantation, such as ischemia-reperfusion injury, alloimmune response, and immunosuppressive treatment and side effects. Although it is still complicated to measure autophagy levels in clinical practice, more attention should be paid to the factors that may influence autophagy. In kidney transplantation, the association of low doses of a mammalian target of rapamycin inhibitor with low doses of a calcineurin inhibitor may be of benefit for autophagy modulation. However, further studies are needed to explore the role of other autophagy regulators.
Identifiants
pubmed: 37953477
doi: 10.1097/TP.0000000000004862
pii: 00007890-990000000-00597
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Ohsumi Y. Historical landmarks of autophagy research. Cell Res. 2014;24:9–23.
Li W, Li J, Bao J. Microautophagy: lesser-known self-eating. Cell Mol Life Sci. 2012;69:1125–1136.
Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018;19:365–381.
Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469:323–335.
Chang YY, Neufeld TP. An Atg1/Atg13 complex with multiple roles in TOR-mediated autophagy regulation. MBoC. 2009;20:2004–2014.
Kraft C, Kijanska M, Kalie E, et al. Binding of the Atg1/ULK1 kinase to the ubiquitin-like protein Atg8 regulates autophagy. EMBO J. 2012;31:3691–3703.
Grunwald DS, Otto NM, Park JM, et al. GABARAPs and LC3s have opposite roles in regulating ULK1 for autophagy induction. Autophagy. 2020;16:600–614.
Russell RC, Tian Y, Yuan H, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. 2013;15:741–750.
Tran S, Fairlie WD, Lee EF. BECLIN1: protein structure, function and regulation. Cells. 2021;10:1522.
Itakura E, Kishi C, Inoue K, et al. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008;19:5360–5372.
Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926–1945.
Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307:1098–1101.
Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132–141.
Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330:1344–1348.
Nazio F, Strappazzon F, Antonioli M, et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol. 2013;15:406–416.
Sarkar S, Rubinsztein DC. Inositol and IP3 levels regulate autophagy—biology and therapeutic speculations. Autophagy. 2006;2:132–134.
Ristow M, Schmeisser KM. promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response. 2014;12:288–341.
Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol. 2001;2:107–117.
McEwan DG, Popovic D, Gubas A, et al. PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins. Mol Cell. 2015;57:39–54.
Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007;8:931–937.
Codogno P, Mehrpour M, Proikas-Cezanne T. Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol. 2011;13:7–12.
Faucher Q, Alarcan H, Marquet P, et al. Effects of ischemia-reperfusion on tubular cell membrane transporters and consequences in kidney transplantation. J Clin Med. 2020;9:2610.
Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. CPB. 2018;46:1650–1667.
Ponticelli C. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transplant. 2014;29:1134–1140.
Farrar CA, Tran D, Li K, et al. Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. J Clin Invest. 2016;126:1911–1925.
Thurman JM, Ljubanovic D, Edelstein CL, et al. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol. 2003;170:1517–1523.
King BC, Kulak K, Colineau L, et al. Outside in: roles of complement in autophagy. Br J Pharmacol. 2021;178:2786–2801.
Howard MC, Nauser CL, Farrar CA, et al. Complement in ischaemia–reperfusion injury and transplantation. Semin Immunopathol. 2021;43:789–797.
Garonzik-Wang JM, Lonze BE, Ruck JM, et al. Mitochondrial membrane potential and delayed graft function following kidney transplantation. Am J Transplant. 2019;19:585–590.
Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93:568–579.
Ponticelli C, Campise MR. The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. Kidney Int. 2021;100:536–545.
McKay LK, White JP. The AMPK/p27Kip1 pathway as a novel target to promote autophagy and resilience in aged cells. Cells. 2021;10:1430.
Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122:927–939.
Li FJ, Xu ZS, Soo ADS, et al. ATP-driven and AMPK-independent autophagy in an early branching eukaryotic parasite. Autophagy. 2017;13:715–729.
Zhang Y, Liu D, Hu H, et al. HIF-1α/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2019;120:109464.
Li L, Tan J, Miao Y, et al. ROS and autophagy: interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 2015;35:615–621.
Xu HD, Qin ZH. Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol. 2019;1206:109–126.
Pallet N. Emerging roles of autophagy in the stressed kidney allograft. Semin Nephrol. 2014;34:34–41.
Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol. 2020;11:591803.
Jiang M, Liu K, Luo J, et al. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol. 2010;176:1181–1192.
Livingston MJ, Wang J, Zhou J, et al. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. Autophagy. 2019;15:2142–2162.
Nam SA, Kim WY, Kim JW, et al. Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway. Cell Death Dis. 2019;10:78.
Decuypere JP, Ceulemans LJ, Agostinis P, et al. Autophagy and the kidney: implications for ischemia-reperfusion injury and therapy. Am J Kidney Dis. 2015;66:699–709.
Livingston MJ, Shu S, Fan Y, et al. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis. Autophagy. 2023;19:256–277.
Tang B, Luo Z, Zhang R, et al. An update on the molecular mechanism and pharmacological interventions for ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy. Cell Signal. 2023;107:110665.
Yun HR, Jo YH, Kim J, et al. Roles of autophagy in oxidative stress. Int J Mol Sci. 2020;21:3289.
Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol. 2009;10:461–470.
Germic N, Frangez Z, Yousefi S, et al. Regulation of the innate immune system by autophagy: neutrophils, eosinophils, mast cells, NK cells. Cell Death Differ. 2019;26:703–714.
López-Soto A, Bravo-San Pedro JM, Kroemer G, et al. Involvement of autophagy in NK cell development and function. Autophagy. 2017;13:633–636.
Harris J. Autophagy and IL-1 family cytokines. Front Immunol. 2013;4:83.
Iida T, Onodera K, Nakase H. Role of autophagy in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2017;23:1944–1953.
Marshall JS, Warrington R, Watson W, et al. An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):49.
Van Kaer L, Parekh VV, Postoak JL, et al. Role of autophagy in MHC class I-restricted antigen presentation. Mol Immunol. 2019;113:2–5.
Puleston DJ, Simon AK. Autophagy in the immune system. Immunology. 2014;141:1–8.
Rudra JS, Khan A, Clover TM, et al. Supramolecular peptide nanofibers engage mechanisms of autophagy in antigen-presenting cells. ACS Omega. 2017;2:9136–9143.
Ghislat G, Lawrence T. Autophagy in dendritic cells. Cell Mol Immunol. 2018;15:944–952.
Botbol Y, Guerrero-Ros I, Macian F. Key roles of autophagy in regulating T-cell function. Eur J Immunol. 2016;46:1326–1334.
Hubbard VM, Valdor R, Patel B, et al. Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol. 2010;185:7349–7357.
Arbogast F, Gros F. Lymphocyte autophagy in homeostasis, activation, and inflammatory diseases. Front Immunol. 2018;9:1801.
Delgoffe GM, Kole TP, Zheng Y, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30:832–844.
Waickman AT, Powell JD. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev. 2012;249:43–58.
Araki K, Turner AP, Shaffer VO, et al. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009;460:108–112.
Verghese DA, Yadav A, Bizargity P, et al. Costimulatory blockade-induced allograft survival requires Beclin1. Am J Transplant. 2014;14:545–553.
Arnold J, Murera D, Arbogast F, et al. Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses. Cell Death Differ. 2016;23:853–864.
Kodali S, Li M, Budai MM, et al. Protection of quiescence and longevity of IgG memory B cells by mitochondrial autophagy. J Immunol. 2022;208:1085–1098.
Sun H, Cheng D, Ma Y, et al. Autophagy in allografts rejection: a new direction? Biochem Biophys Res Commun. 2016;471:572–575.
Zhang K, Huang Q, Peng L, et al. The multifunctional roles of autophagy in the innate immune response: implications for regulation of transplantation rejection. Front Cell Dev Biol. 2022;10:1007559.
Pua HH, Dzhagalov I, Chuck M, et al. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med. 2007;204:25–31.
Wu YX, Jin SH, Cui J. Autophagy and immune tolerance. Adv Exp Med Biol. 2019;1206:635–665.
Cui J, Yu J, Xu H, et al. Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation. Theranostics. 2020;10:8051–8060.
Ma Y, Galluzzi L, Zitvogel L, et al. Autophagy and cellular immune responses. Immunity. 2013;39:211–227.
Harper SJF, Ali JM, Wlodek E, et al. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection. Proc Natl Acad Sci U S A. 2015;112:12788–12793.
Xu X, Araki K, Li S, et al. Autophagy is essential for effector CD8+ T cell survival and memory formation. Nat Immunol. 2014;15:1152–1161.
Chen X, Wang L, Deng Y, et al. Inhibition of autophagy prolongs recipient survival through promoting CD8+ T cell apoptosis in a rat liver transplantation model. Front Immunol. 2019;10:1356.
Yap M, Brouard S, Pecqueur C, et al. Targeting CD8 T-cell metabolism in transplantation. Front Immunol. 2015;6:547.
Halamay KE, Kirkman RL, Sun L, et al. CD8 T cells are sufficient to mediate allorecognition and allograft rejection. Cell Immunol. 2002;216:6–14.
Yap M, Boeffard F, Clave E, et al. Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction. J Am Soc Nephrol. 2014;25:1856–1868.
Hogan PG, Chen L, Nardone J, et al. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17:2205–2232.
Schofield JH, Schafer ZT. Mitochondrial reactive oxygen species and mitophagy: a complex and nuanced relationship. Antioxid Redox Signal. 2021;34:517–530.
Kim JW, Nam SA, Seo E, et al. Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy. Korean J Intern Med. 2021;36:1420–1436.
Cao R, Li Y, Hu X, et al. Glycyrrhizic acid improves tacrolimus-induced renal injury by regulating autophagy. FASEB J. 2023;37:e22749.
Lim SW, Shin YJ, Luo K, et al. Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury. FASEB J. 2019;33:2694–2706.
Wu Q, Wang X, Nepovimova E, et al. Mechanism of cyclosporine A nephrotoxicity: oxidative stress, autophagy, and signalings. Food Chem Toxicol. 2018;118:889–907.
Pallet N, Bouvier N, Legendre C, et al. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy. 2008;4:783–791.
Qi Z, Chen L. Endoplasmic reticulum stress and autophagy. Adv Exp Med Biol. 2019;1206:167–177.
Lim SW, Hyoung BJ, Piao SG, et al. Chronic cyclosporine nephropathy is characterized by excessive autophagosome formation and decreased autophagic clearance. Transplantation. 2012;94:218–225.
Li ZH, An N, Huang XJ, et al. Cyclosporine A blocks autophagic flux in tubular epithelial cells by impairing TFEB-mediated lysosomal function. J Cell Mol Med. 2021;25:5729–5743.
Khanna A, Plummer M, Bromberek C, et al. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int. 2002;62:2257–2263.
Maluccio M, Sharma V, Lagman M, et al. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation. 2003;76:597–602.
Ding Y, Choi ME. Regulation of autophagy by TGF-β: emerging role in kidney fibrosis. Semin Nephrol. 2014;34:62–71.
Ding Y, Kim S, Lee SY, et al. Autophagy regulates TGF-β expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction. J Am Soc Nephrol. 2014;25:2835–2846.
Lim SW, Jin L, Jin J, et al. Effect of Exendin-4 on autophagy clearance in beta cell of rats with tacrolimus-induced diabetes mellitus. Sci Rep. 2016;6:29921.
Park K, Sonn SK, Seo S, et al. Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunction. Autophagy. 2023;19:1444–1458.
Lim SW, Jin L, Luo K, et al. Ginseng extract reduces tacrolimus-induced oxidative stress by modulating autophagy in pancreatic beta cells. Lab Invest. 2017;97:1271–1281.
Textor SC, Taler SJ, Canzanello VJ, et al. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl. 2000;6:521–530.
McCarthy CG, Wenceslau CF, Calmasini FB, et al. Reconstitution of autophagy ameliorates vascular function and arterial stiffening in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2019;317:H1013–H1027.
Saran U, Foti M, Dufour JF. Cellular and molecular effects of the mTOR inhibitor everolimus. Clin Sci (Lond). 2015;129:895–914.
Ballesteros-Álvarez J, Andersen JK. mTORC2: the other mTOR in autophagy regulation. Aging Cell. 2021;20:e13431.
Sun Y, Wang H, Qu T, et al. mTORC2: a multifaceted regulator of autophagy. Cell Commun Signal. 2023;21:4.
Dai H, Thomson AW. The “other” mTOR complex: new insights into mTORC2 immunobiology and their implications. Am J Transplant. 2019;19:1614–1621.
O’Shea AE, Valdera FA, Ensley D, et al. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention. Clin Immunol. 2022;245:109095.
Araki K, Youngblood B, Ahmed R. The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev. 2010;235:234–243.
Basu S, Golovina T, Mikheeva T, et al. Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol. 2008;180:5794–5798.
Ponticelli C. The pros and the cons of mTOR inhibitors in kidney transplantation. Expert Rev Clin Immunol. 2014;10:295–305.
Li H, Peng X, Wang Y, et al. Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis. Autophagy. 2016;12:1472–1486.
Gui Z, Suo C, Wang Z, et al. Impaired ATG16L-dependent autophagy promotes renal interstitial fibrosis in chronic renal graft dysfunction through inducing EndMT by NF-κB signal pathway. Front Immunol. 2021;12:650424.
Gui Z, Suo C, Tao J, et al. Everolimus alleviates renal allograft interstitial fibrosis by inhibiting epithelial-to-mesenchymal transition not only via inducing autophagy but also via stabilizing IκB-α. Front Immunol. 2021;12:753412.
Ruby M, Gifford CC, Pandey R, et al. Autophagy as a therapeutic target for chronic kidney disease and the roles of TGF-β1 in autophagy and kidney fibrosis. Cells. 2023;12:412.
Inoue K, Kuwana H, Shimamura Y, et al. Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol. 2010;14:112–122.
Sansanwal P, Yen B, Gahl WA, et al. Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol. 2010;21:272–283.
Lupinacci S, Perri A, Toteda G, et al. Rapamycin promotes autophagy cell death of Kaposi’s sarcoma cells through P75NTR activation. Exp Dermatol. 2022;31:143–153.
Wang L, Heckmann BL, Yang X, et al. Osteoblast autophagy in glucocorticoid-induced osteoporosis. J Cell Physiol. 2019;234:3207–3215.
Xiao Y, Ren Q, Zheng Y, et al. Geniposide ameliorated dexamethasone-induced endoplasmic reticulum stress and mitochondrial apoptosis in osteoblasts. J Ethnopharmacol. 2022;291:115154.
Clemente-Postigo M, Tinahones A, El Bekay R, et al. The role of autophagy in white adipose tissue function: implications for metabolic health. Metabolites. 2020;10:179.
Marcelin G, Da Cunha C, Gamblin C, et al. Autophagy inhibition blunts PDGFRA adipose progenitors’ cell-autonomous fibrogenic response to high-fat diet. Autophagy. 2020;16:2156–2166.
Wang J, Wang R, Wang H, et al. Glucocorticoids suppress antimicrobial autophagy and nitric oxide production and facilitate mycobacterial survival in macrophages. Sci Rep. 2017;7:982.
Sato M, Ueda E, Konno A, et al. Glucocorticoids negatively regulates chaperone mediated autophagy and microautophagy. Biochem Biophys Res Commun. 2020;528:199–205.
Wu T, Shao Y, Li X, et al. NR3C1/glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity. Autophagy. 2023;19:2538–2557.
Sarsenbayeva A, Jui BN, Fanni G, et al. Impaired HMG-CoA reductase activity caused by genetic variants or statin exposure: impact on human adipose tissue, β-cells and metabolome. Metabolites. 2021;11:574.
Wu MY, Lu JH. Autophagy and macrophage functions: inflammatory response and phagocytosis. Cells. 2019;9:70.
Deng J, Guo Y, Yuan F, et al. Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressing BAT whitening. Autophagy. 2020;16:451–465.
Ro SH, Jang Y, Bae J, et al. Autophagy in adipocyte browning: emerging drug target for intervention in obesity. Front Physiol. 2019;10:22.
Di Lernia G, Leone P, Solimando AG, et al. Bortezomib treatment modulates autophagy in multiple myeloma. J Clin Med. 2020;9:552.
Walsh RC, Alloway RR, Girnita AL, et al. Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int. 2012;81:1067–1074.
Cheng H, Xu B, Zhang L, et al. Bortezomib alleviates antibody-mediated rejection in kidney transplantation by facilitating Atg5 expression. J Cell Mol Med. 2021;25:10939–10949.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021;17:1–382.
Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci . 2017;18:1865.
Loos B, du Toit A, Hofmeyr JHS. Defining and measuring autophagosome flux—concept and reality. Autophagy. 2014;10:2087–2096.
Loos B, Klionsky DJ, Du Toit A, et al. On the relevance of precision autophagy flux control in vivo—points of departure for clinical translation. Autophagy. 2020;16:750–762.
Beesabathuni NS, Park S, Shah PS. Quantitative and temporal measurement of dynamic autophagy rates. Autophagy. 2023;19:1164–1183.
Song H, Dong C, Ren J. In vivo measurement of autophagic flux by fluorescence correlation spectroscopy. Analyst. 2023;148:3498–3508.
Sakurai HT, Iwashita H, Arakawa S, et al. Development of small fluorescent probes for the analysis of autophagy kinetics. iScience. 2023;26:107218.
Salvadori M, Scolari MP, Bertoni E, et al. Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. Transplantation. 2009;88:1194–1202.
Ponticelli C, Salvadori M, Scolari MP, et al.; EVEREST Study. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study. Transplantation. 2011;91:e72–e73.
Pascual J, Berger SP, Witzke O, et al.; TRANSFORM Investigators. Everolimus with reduced calcineurin inhibitor exposure in renal transplantation. J Am Soc Nephrol. 2018;29:1979–1991.
Cucchiari D, Ríos J, Molina-Andujar A, et al. Combination of calcineurin and mTOR inhibitors in kidney transplantation: a propensity score analysis based on current clinical practice. J Nephrol. 2020;33:601–610.
Gao L, Xu F, Cheng H, et al. Comparison of sirolimus combined with tacrolimus and mycophenolate mofetil combined with tacrolimus in kidney transplantation recipients: a meta-analysis. Transplant Proc. 2018;50:3306–3313.
Bharath LP, Agrawal M, McCambridge G, et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 2020;32:44–55.e6.
Bhutia SK. Vitamin D in autophagy signaling for health and diseases: insights on potential mechanisms and future perspectives. J Nut Biochem. 2022;99:108841.
Wei YM, Wang YH, Xue HQ, et al. Triptolide, a potential autophagy modulator. Chin J Integr Med. 2019;25:233–240.
Cook KL, Wärri A, Soto-Pantoja DR, et al. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer. Clin Cancer Res. 2014;20:3222–3232.
Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435–1455.